RachelMarieHurleyMDPhD

PubMed

• 5 citations
  A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovari...
  Julia Manzo, Shannon Puhalla, Shalu Pahuja, Fei Ding, Yan Lin, Leonard Appleman, Hussein Tawbi, Ronald Stoller, James J Lee, Brenda Diergaarde, Brian F Kiesel, Jing Yu...> ;Cancer Chemotherapy and Pharmacology. 2022 May 1
• CHFR and Paclitaxel Sensitivity of Ovarian Cancer.
  Andrea E Wahner Hendrickson, Daniel W Visscher, Xiaonan Hou, Krista M Goergen, Hunter J Atkinson, Thomas G Beito, Vivian Negron, Wilma L Lingle, Amy K Bruzek, Rachel M...> ;Cancers. 2021 Nov 30
• 10 citations
  Acquired RAD51C Promoter Methylation Loss Causes PARP Inhibitor Resistance in High-Grade Serous Ovarian Carcinoma
  Ksenija Nesic, Olga Kondrashova, Rachel M. Hurley, Cordelia D. McGehee, Cassandra J. Vandenberg, Gwo-Yaw Ho, Elizabeth Lieschke, Genevieve Dall, Nirashaa Bound, Kristy...> ;Cancer Research. 2021 Sep 15
• 16 citations
  Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance
  Rachel M. Hurley, Cordelia D. McGehee, Ksenija Nesic, Cristina Correia, Taylor M. Weiskittel, Rebecca L. Kelly, Annapoorna Venkatachalam, Xiaonan Hou, Nicholas M. Path...> ;NAR Cancer. 2021 Jul 2
• 8 citations
  Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
  Ann L. Oberg, Ethan P. Heinzen, Xiaonan Hou, Mariam M. Al Hilli, Rachel M. Hurley, Andrea E. Wahner Hendrickson, Krista M. Goergen, Melissa C. Larson, Marc A. Becker, ...> ;Scientific Reports. 2021 Apr 13
• Hereditary Thrombotic Thrombocytopenic Purpura in a 9-Month-old: Diagnosing and Managing an Ultra-rare Disorder.
  Kirk D. Wyatt, Mira A. Kohorst, Lea M. Coon, Rachel M. Hurley, Hendrika Anette van Dorland, Carola A.S. Arndt> ;Journal of Pediatric Hematology/oncology. 2021 May 1
• 6 citations
  Poly (ADP-Ribose) Polymerase Inhibition for Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Placebo-Controlled Trials
  Ryan A. Balko, Rachel M. Hurley, Aminah Jatoi> ;Journal of Palliative Medicine. 2019 Aug 1
• 52 citations
  53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer
  Rachel M. Hurley, Andrea E. Wahner Hendrickson, Daniel W. Visscher, Peter Ansell, Maria I. Harrell, Jill M. Wagner, Vivian Negron, Krista M. Goergen, Matthew J. Maurer...> ;Gynecologic Oncology. 2019 Apr 1
• 48 citations
  In vivo anti-tumor activity of the PARP inhibitor niraparib in homologous recombination deficient and proficient ovarian carcinoma
  Mariam M. AlHilli, Marc A. Becker, S. John Weroha, Karen S. Flatten, Rachel M. Hurley, Maria I. Harrell, Ann L. Oberg, Matt J. Maurer, Kieran M. Hawthorne, Xiaonan Hou...> ;Gynecologic Oncology. 2016 Nov 1
• 36 citations
  Targeting Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of Tumor Cell Invasion
  Gina L. Razidlo, Christopher Magnine, Arthur C. Sletten, Rachel M. Hurley, Luciana L. Almada, Martin E. Fernandez-Zapico, Baoan Ji, Mark A. McNiven> ;Cancer Research. 2015 Jul 15
• 3 citations
  Challenges in the Management of Giant Intraductal Breast Papilloma
  Yasaman Fatemi, Rachel M. Hurley, Clive S. Grant, Tara L. Henrichsen, Beiyun Chen, Karthik Ghosh> ;Clinical Case Reports. 2015 Jan 1
• 86 citations
  The Elephant and the Blind Men: Making Sense of PARP Inhibitors in Homologous Recombination Deficient Tumor Cells.
  Silvana B. De Lorenzo, Anand Patel, Rachel M. Hurley, Scott H. Kaufmann> ;Frontiers in Oncology. 2013 Sep 11
• 22 citations
  Redifferentiation and induction of tumor suppressors miR-122 and miR-375 by the PAX8/PPARγ fusion protein inhibits anaplastic thyroid cancer: a novel therapeutic strat...
  Honey V. Reddi, C B Driscoll, Pranathi Madde, Dragana Milosevic, R M Hurley, Samantha J. McDonough, J Hallanger-Johnson, Bryan McIver, Norman L. Eberhardt> ;Cancer Gene Therapy. 2013 Apr 19
• Join now to see all